Investor Zone
"You Build Hope...
We Accelerate It"
We strive for continuous improvement to create value for our all stakeholders
Our Managing Directors
Rahul Batra
Chairman & Managing Director
Varun Batra
Joint Managing DirectorOur Directors
Balwant Singh
Seema Chopra
Dr. Rohit Parti
Manmohan Khanna
Ashutosh Shukla
Our CS/CFO's
Nipun Arora
Chief Financial Officer
Rajni Brar
Company Secretary
- Code of Conduct
- Code of Internal Procedures & Conduct
- Policy for determining Material Subsidiaries
- Policy on Archival of Documents
- Whistle Blower Policy
- Criteria for Determining Materiality of Events
- Policy on Preservation of Documents
- Policy on Related Party Transaction
- Policy on Remuneration Nomination and Boar Diversity
- CSR POLICY
- Notice dated 04.02.2019
- Notice dated 01.03.2019
- Notice dated 23.03.2019
- Notice dated 28.03.2019
- Notice dated 01.05.2019
- Notice dated 13.05.2019
- Notice dated 29.05.2019
- Notice dated 01.07.2019
- Notice dated 01.08.2019
- Notice dated 31.08.2019
- Notice dated 27.09.2019
- Notice dated 23.10.2019
- Notice dated 08.11.2019
- Notice dated 22.11.2019
- Pattern dated 11.10.2017
- Pattern dated 31.03.2018
- Pattern dated 30.09.2018
- Pattern dated 31.03.2019
- Pattern dated 01.05.2019
- Pattern dated 30.09.2019
- Pattern dated 31.03.2020
- Pattern dated 30.06.2020
- Pattern dated 30.09.2020
- Pattern dated 31.12.2020
- Pattern dated 31.03.2020
- Pattern dated 30.06.2021
- Pattern dated 30.09.2021
- Shareholding Pattern dated 31.12.2021
- Pattern Dated 31.03.2022.pdf
- 20 product reg certificates from Ministry of Health Uzbekistan 27.04.2020
- Acquisition of Adley Formulations 05.11.2018
- Adley lab Ltd received WHO GMP 19.07.2021
- Azer News Beta 20.10.2018
- Medyra Pharmaceuticals Baddi facility receives philippines GMP Certification 12.07.2018
- International Plant Approvals 15.11.2019
- Intimation of Acquisition of 100 shares of Adley lab limited 25.10.2019
- Intimation of Concall 17.05.2018
- Intimation of Incorporation of a Wholly Owned Subsidiary Company 11.10.2018
- Intimation of Incorporation of Subsidiary in Republic of Uzbekistan 18.10.2018
- Intimation of Investor Meet 24.04.2019
- Launch of Axitinib by Medyra Pharmaceuticals Limited 04.09.2020
- lmpact of COVID 19 pandemic on the business of the Company 23.06.2020
- New Product Launches 12.06.2020
- Update on Beta Uzbekistan Subsidiary 12.03.2019
- Update on Beta Uzbekistan Subsidiary 16.08.2019
- Update on New Product launches to drive growth for Medyra Pharmaceuticals
- Update on Medyra Pharmaceuticals received DCGI NOF for MDS
- Update on Medyra Pharmaceuticals API plant ready to take big leap
- Update on Medyra Pharmaceuticals API plant ready to take big leap
- New product launch to drive growth for Medyra Pharmaceuticals.PDF
- Medyra Pharmaceuticals Ltd. bags yet another DCGI approval for its new drug_ KABONIB after MDS-O
- Financial Statement of Adley Formulations Pvt Ltd as on 31.03.2019
- Financial Statement of Adley Formulations Pvt Ltd as on 31.03.2020
- Financial Statement of Adley Lab Limited as on 31.03.2020
- Financial Statement of Adley Formulations Pvt Ltd as on 31.03.2021
- Financial Statement of Adley Lab Ltd as on 31.03.2021
Registrars and Shares Transfer Agent
Link Intime India Pvt. Ltd
C 101, 247 Park, L.B.S.Marg,
Vikhroli (West), Mumbai.-400083
+022-4918 6270
mumbai@linkintime.co.in
Investors/Shareholders Grievance Redressal
Mrs. Rajni Brar
Company Secretary & Compliance Officer
cs@medyrapharmaceutical.com
0172-2585481, 482
Authorised KMPs for Determining Materiality of events
Mr Rahul Batra
Managing Director
0172-2585481, 482